Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 09, 2018

SELL
$12.27 - $15.65 $1,950 - $2,488
-159 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$14.59 - $25.5 $83,483 - $145,911
-5,722 Reduced 97.3%
159 $3,000
Q4 2017

Feb 16, 2018

BUY
$15.77 - $20.72 $92,743 - $121,854
5,881
5,881 $106,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.28B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.